Last Posted: Sep 06, 2018
- BRCA1 and BRCA2 Testing in Medically Underserved Medicare Beneficiaries With Breast or Ovarian Cancer.
Gross Amy L et al. JAMA 2018 Aug 320(6) 597-598 - Cancer genetics, precision prevention and a call to action.
Turnbull Clare et al. Nature genetics 2018 Sep 50(9) 1212-1218 - Researchers find a way to mimic clinical trials using genetics A technique called Mendelian randomization could be the revolutionary tool drug companies have been waiting for.
G Tauber, MIT Tech Review, August 28, 2018 - A Harvard Scientist Thinks He Has a Gene Test for Heart Attack Risk. He Wants to Give It Away Free.
M Herper, Forbes, August 13, 2018 - Cost Effectiveness of Genotype-Guided Warfarin Dosing in Patients with Mechanical Heart Valve Replacement Under the Fee-for-Service System.
Kim Dong-Jin et al. Applied health economics and health policy 2017 Oct 15(5) 657-667 - Precision Public Health and Genomic Medicine
Healthcare special supplement, 2018 - Qualitative Research to Explore the Patient Experience of X-Linked Hypophosphatemia and Evaluate the Suitability of the BPI-SF and WOMAC® as Clinical Trial End Points.
Theodore-Oklota Christina et al. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2018 Aug 21(8) 973-983 - Would Routine Genomic Testing For Cancer And Heart Risk Make Economic Sense?
A Weintraub, Forbes, July 30, 2018 - Clinical Impact and Cost-Effectiveness of a 176-Condition Expanded Carrier Screen
KA Beachamp et al, BioRXIV, July 2018 - Cost-effective screening of DNMT3A coding sequence identifies somatic mutation in pediatric T-cell acute lymphoblastic leukemia.
Szarzynska-Zawadzka Bronislawa et al. European journal of haematology 2017 Dec 99(6) 514-519
.png)
No hay comentarios:
Publicar un comentario